UBS Group »

Immunovant shares owned by UBS Group

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 155k 42.13
2023-09-30 $3.3M 85k 38.39
2023-06-30 $1.7M 92k 18.97
2023-03-31 $1.9M 123k 15.51
2022-12-31 $2.7M 154k 17.75
2022-09-30 $38k 7.0k 5.50
2022-06-30 $9.1k 2.3k 4.00
2021-12-31 $1.4M 167k 8.52
2021-09-30 $423k 49k 8.68
2021-06-30 $387k 37k 10.56
2021-03-31 $1.3M 83k 16.04
2020-12-31 $2.3M 49k 46.38
2020-09-30 $30k 839 35.76
2020-06-30 $169k 7.0k 24.30
2020-03-31 $37k 2.4k 15.70
2019-12-31 $17k 1.1k 15.80